Immune–metabolic interactions in homeostasis and the progression to NASH

Si-Tayeb, 2010, Developmental cell organogenesis and development of the liver, Dev. Cell, 18, 175, 10.1016/j.devcel.2010.01.011 Haas, 2016, Pathophysiology and mechanisms of nonalcoholic fatty liver disease, Annu. Rev. Physiol., 78, 181, 10.1146/annurev-physiol-021115-105331 Neuschwander-Tetri, 2010, Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites, Hepatology, 52, 774, 10.1002/hep.23719 Horn, 2022, Role of cholesterol-associated steatohepatitis in the development of NASH, Hepatol. Commun., 6, 12, 10.1002/hep4.1801 Bence, 2020, Metabolic drivers of non-alcoholic fatty liver disease, Mol. Metab., 50 Laursen, 2019, Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects, World J. Hepatol., 11, 138, 10.4254/wjh.v11.i2.138 Marra, 2018, Lipotoxicity and the gut-liver axis in NASH pathogenesis, J. Hepatol., 68, 280, 10.1016/j.jhep.2017.11.014 Kleiner, 2019, Association of histologic disease activity with progression of nonalcoholic fatty liver disease, JAMA Netw. Open, 2, 10.1001/jamanetworkopen.2019.12565 Schuppan, 2018, Determinants of fibrosis progression and regression in NASH, J. Hepatol., 68, 238, 10.1016/j.jhep.2017.11.012 Yki-Järvinen, 2021, Dietary carbohydrates and fats in nonalcoholic fatty liver disease, Nat. Rev. Gastroenterol. Hepatol., 18, 770, 10.1038/s41575-021-00472-y Ibrahim, 2018, Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation, Gut, 67, 963, 10.1136/gutjnl-2017-315691 Bartneck, 2016, Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease, Hepatology, 63, 1310, 10.1002/hep.28418 Leroux, 2012, Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis, J. Hepatol., 57, 141, 10.1016/j.jhep.2012.02.028 Govaere, 2022, Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease, J. Hepatol., 76, 1001, 10.1016/j.jhep.2021.12.012 Daemen, 2021, Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH, Cell Rep., 34, 10.1016/j.celrep.2020.108626 Seidman, 2020, Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis, Immunity, 52, 1057, 10.1016/j.immuni.2020.04.001 Mogilenko, 2019, Metabolic and Innate immune cues merge into a specific inflammatory response via the UPR, Cell, 177, 1201, 10.1016/j.cell.2019.03.018 Haas, 2019, Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution, Nat. Metab., 1, 604, 10.1038/s42255-019-0076-1 Stentz, 2006, Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation, Biochem. Biophys. Res. Commun., 346, 721, 10.1016/j.bbrc.2006.05.159 Fernanda Cury-Boaventura, 2006, Mechanisms involved in Jurkat cell death induced by oleic and linoleic acids, Clin. Nutr., 25, 1004, 10.1016/j.clnu.2006.05.008 de Jong, 2014, Fatty acids, lipid mediators, and T-cell function, Front. Immunol., 5, 1, 10.3389/fimmu.2014.00483 Newsholme, 1987, Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages, Biochem. J., 242, 631, 10.1042/bj2420631 van Uden, 2008, Regulation of hypoxia-inducible factor-1α by NF-κB, Biochem. J., 412, 477, 10.1042/BJ20080476 Arranz, 2012, Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization, Proc. Natl. Acad. Sci. U. S. A., 109, 9517, 10.1073/pnas.1119038109 Cheng, 2014, mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity, Science (80-. ), 345, 1250684, 10.1126/science.1250684 Viola, 2019, The metabolic signature of macrophage responses, Front. Immunol., 10, 1462, 10.3389/fimmu.2019.01462 Huang, 2010, Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance, Diabetes, 59, 347, 10.2337/db09-0016 Plas, 2002, Homeostatic control of lymphocyte survival: potential origins and implications, Nat. Immunol., 3, 515, 10.1038/ni0602-515 Fox, 2005, Fuel feeds function: energy metabolism and the T-cell response, Nat. Rev. Immunol., 5, 844, 10.1038/nri1710 Frauwirth, 2002, The CD28 signaling pathway regulates glucose metabolism, Immunity, 16, 769, 10.1016/S1074-7613(02)00323-0 Enjoji, 2012, Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol, Int. J. Hepatol., 2012, 1, 10.1155/2012/464706 Endo-Umeda, 2018, Dysregulation of Kupffer cells/macrophages and natural killer T cells in steatohepatitis in LXR α knockout male mice, Endocrinology, 159, 1419, 10.1210/en.2017-03141 Endo-Umeda, 2019, Liver X receptors regulate cholesterol metabolism and immunity in hepatic nonparenchymal cells, Int. J. Mol. Sci., 20, 5045, 10.3390/ijms20205045 Campbell, 2020, Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells, Nature, 581, 475, 10.1038/s41586-020-2193-0 Hang, 2019, Bile acid metabolites control TH17 and Treg cell differentiation, Nature, 576, 143, 10.1038/s41586-019-1785-z Song, 2020, Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis, Nature, 577, 410, 10.1038/s41586-019-1865-0 Chávez-Talavera, 2019, Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes, Curr. Opin. Lipidol., 30, 244, 10.1097/MOL.0000000000000597 Puri, 2018, The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids, Hepatology, 67, 534, 10.1002/hep.29359 Chen, 2020, Genetic and microbial associations to plasma and fecal bile acids in obesity relate to plasma lipids and liver fat content, Cell Rep., 33, 10.1016/j.celrep.2020.108212 Grzych, 2021, NASH-related increases in plasma bile acid levels depend on insulin resistance, JHEP Rep., 3 Gola, 2021, Commensal-driven immune zonation of the liver promotes host defence, Nature, 589, 131, 10.1038/s41586-020-2977-2 Guilliams, 2022, Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches, Cell, 185, 379, 10.1016/j.cell.2021.12.018 Bonnardel, 2019, Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche, Immunity, 51, 638, 10.1016/j.immuni.2019.08.017 Jenne, 2013, Immune surveillance by the liver, Nat. Immunol., 14, 996, 10.1038/ni.2691 Sun, 2019, Fungal dissemination is limited by liver macrophage filtration of the blood, Nat. Commun., 10, 4566, 10.1038/s41467-019-12381-5 Heymann, 2015, Liver inflammation abrogates immunological tolerance induced by Kupffer cells, Hepatology, 62, 279, 10.1002/hep.27793 McDonald, 2020, Programing of an intravascular immune firewall by the gut microbiota protects against pathogen dissemination during infection, Cell Host Microbe, 28, 660, 10.1016/j.chom.2020.07.014 Park, 2007, Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients, J. Gastroenterol. Hepatol., 22, 491, 10.1111/j.1440-1746.2006.04758.x Lotowska, 2013, The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis-ultrastructural findings. the first report in pediatric patients, Scand. J. Gastroenterol., 48, 352, 10.3109/00365521.2012.746390 Gadd, 2014, The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease, Hepatology, 59, 1393, 10.1002/hep.26937 Itoh, 2013, Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans, PLoS One, 8, 10.1371/journal.pone.0082163 Rensen, 2009, Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis, Am. J. Pathol., 175, 1473, 10.2353/ajpath.2009.080999 Ioannou, 2013, Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis, J. Lipid Res., 54, 1326, 10.1194/jlr.M034876 Neyrinck, 2009, Critical role of Kupffer cells in the management of diet-induced diabetes and obesity, Biochem. Biophys. Res. Commun., 385, 351, 10.1016/j.bbrc.2009.05.070 Lanthier, 2010, Kupffer cell activation is a causal factor for hepatic insulin resistance, Am. J. Physiol. Liver Physiol., 298, G107 Tacke, 2014, Macrophage heterogeneity in liver injury and fibrosis, J. Hepatol., 60, 1090, 10.1016/j.jhep.2013.12.025 Morinaga, 2015, Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice, Diabetes, 64, 1120, 10.2337/db14-1238 Scott, 2018, The transcription factor ZEB2 is required to maintain the tissue-specific identities of macrophages, Immunity, 49, 312, 10.1016/j.immuni.2018.07.004 Sakai, 2019, Liver-derived signals sequentially reprogram myeloid enhancers to initiate and maintain Kupffer cell identity, Immunity, 51, 655, 10.1016/j.immuni.2019.09.002 Deng, 2009, Immature myeloid cells induced by a high-fat diet contribute to liver inflammation, Hepatology, 50, 1412, 10.1002/hep.23148 Krenkel, 2018, Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis, Hepatology, 67, 1270, 10.1002/hep.29544 Miura, 2012, Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2, Am. J. Physiol. Liver Physiol., 302, G1310 Yang, 2009, Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy, Diabetologia, 52, 972, 10.1007/s00125-009-1309-8 Baeck, 2012, Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury, Gut, 61, 416, 10.1136/gutjnl-2011-300304 Remmerie, 2020, Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver, Immunity, 53, 641, 10.1016/j.immuni.2020.08.004 Tran, 2020, Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis, Immunity, 53, 627, 10.1016/j.immuni.2020.06.003 Im, 2021, A systematic review of animal models of NAFLD finds high-fat, high-fructose diets most closely resemble human NAFLD, Hepatology, 74, 1884, 10.1002/hep.31897 Hasegawa, 2018, Mechanisms of tolerance induction by dendritic cells in vivo, Front. Immunol., 9, 1, 10.3389/fimmu.2018.00350 Audiger, 2017, The importance of dendritic cells in maintaining immune tolerance, J. Immunol., 198, 2223, 10.4049/jimmunol.1601629 Miller, 2012, Deciphering the transcriptional network of the dendritic cell lineage, Nat. Immunol., 13, 888, 10.1038/ni.2370 Guilliams, 2014, Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny, Nat. Rev. Immunol., 14, 571, 10.1038/nri3712 Mildner, 2014, Development and function of dendritic cell subsets, Immunity, 40, 642, 10.1016/j.immuni.2014.04.016 Kelly, 2014, CD141+ myeloid dendritic cells are enriched in healthy human liver, J. Hepatol., 60, 135, 10.1016/j.jhep.2013.08.007 Shu, 2007, The role of CD11c+ hepatic dendritic cells in the induction of innate immune responses, Clin. Exp. Immunol., 149, 335, 10.1111/j.1365-2249.2007.03419.x Asselin-Paturel, 2005, Type I interferon dependence of plasmacytoid dendritic cell activation and migration, J. Exp. Med., 201, 1157, 10.1084/jem.20041930 Ferris, 2020, cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity, Nature, 584, 624, 10.1038/s41586-020-2611-3 Deczkowska, 2021, XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis, Nat. Med., 27, 1043, 10.1038/s41591-021-01344-3 Febbraio, 2019, Preclinical models for studying NASH-driven HCC: how useful are they?, Cell Metab., 29, 18, 10.1016/j.cmet.2018.10.012 Heier, 2017, Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis, J. Hepatol., 66, 1241, 10.1016/j.jhep.2017.01.008 Kolaczkowska, 2013, Neutrophil recruitment and function in health and inflammation, Nat. Rev. Immunol., 13, 159, 10.1038/nri3399 Tecchio, 2014, Neutrophil-derived cytokines: facts beyond expression, Front. Immunol., 5, 508, 10.3389/fimmu.2014.00508 Brinkmann, 2004, Neutrophil extracellular traps kill bacteria, Science (80-. ), 303, 1532, 10.1126/science.1092385 Takei, 1996, Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosis, J. Leukoc. Biol., 59, 229, 10.1002/jlb.59.2.229 Yipp, 2012, Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo, Nat. Med., 18, 1386, 10.1038/nm.2847 Bertola, 2010, Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients, PLoS ONE, 5, 10.1371/journal.pone.0013577 Chang, 2015, Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1, Hepatology, 62, 1070, 10.1002/hep.27921 van der Windt, 2018, Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis, Hepatology, 68, 1347, 10.1002/hep.29914 Gao, 2016, Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?, Gastroenterology, 150, 1704, 10.1053/j.gastro.2016.01.025 Hwang, 2020, Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets, Hepatology, 72, 412, 10.1002/hep.31031 Antonucci, 2020, Circulating neutrophils of nonalcoholic steatohepatitis patients show an activated phenotype and suppress T lymphocytes activity, J Immunol Res, 2020, 1, 10.1155/2020/4570219 He, 2021, Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223–enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis, J. Clin. Invest., 131 Kim, 2021, Dual role of neutrophils in modulating liver injury and fibrosis during development and resolution of diet-induced murine steatohepatitis, Sci. Rep., 11, 1, 10.1038/s41598-021-03679-w Ficht, 2020, Immune surveillance of the liver by T cells, Sci. Immunol., 5, eaba2351, 10.1126/sciimmunol.aba2351 Rau, 2016, Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17/resting regulatory T cell ratio in peripheral blood and in the liver, J. Immunol., 196, 97, 10.4049/jimmunol.1501175 Pacifico, 2006, Increased T-helper interferon-γ-secreting cells in obese children, Eur. J. Endocrinol., 154, 691, 10.1530/eje.1.02138 Ferreyra Solari, 2012, The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis, J. Clin. Immunol., 32, 611, 10.1007/s10875-011-9635-2 Inzaugarat, 2011, Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis, J. Clin. Immunol., 31, 1120, 10.1007/s10875-011-9571-1 Gomes, 2016, Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma, Cancer Cell, 30, 161, 10.1016/j.ccell.2016.05.020 Her, 2020, CD4+ T cells mediate the development of liver fibrosis in high fat diet-induced NAFLD in humanized mice, Front. Immunol., 11, 10.3389/fimmu.2020.580968 Rolla, 2016, The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice, Clin. Sci., 130, 193, 10.1042/CS20150405 Ma, 2007, A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury, Hepatology, 46, 1519, 10.1002/hep.21823 Wang, 2021, Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis, J. Hepatol., 75, 1271, 10.1016/j.jhep.2021.07.032 Dywicki, 2022, The detrimental role of regulatory T cells in nonalcoholic steatohepatitis, Hepatol. Commun., 6, 320, 10.1002/hep4.1807 Vonghia, 2015, CD4+ROR γ t++ and Tregs in a mouse model of diet-induced nonalcoholic steatohepatitis, Mediat. Inflamm., 2015, 1, 10.1155/2015/239623 Van Herck, 2019, The differential roles of T cells in non-alcoholic fatty liver disease and obesity, Front. Immunol., 10, 82, 10.3389/fimmu.2019.00082 Bhattacharjee, 2017, Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis, Hepatol. Commun., 1, 299, 10.1002/hep4.1041 Wolf, 2014, Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes, Cancer Cell, 26, 549, 10.1016/j.ccell.2014.09.003 Alegre, 2020, Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease, Clin. Mol. Hepatol., 26, 216, 10.3350/cmh.2019.0074 Dudek, 2021, Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH, Nature, 592, 444, 10.1038/s41586-021-03233-8 Ma, 2016, NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis, Nature, 531, 253, 10.1038/nature16969 Hansel, 2019, The inhibitory T cell receptors PD1 and 2B4 are differentially regulated on CD4 and CD8 T cells in a mouse model of non-alcoholic steatohepatitis, Front. Pharmacol., 10, 244, 10.3389/fphar.2019.00244 Pfister, 2021, NASH limits anti-tumour surveillance in immunotherapy-treated HCC, Nature, 592, 450, 10.1038/s41586-021-03362-0 Breuer, 2020, CD8 + T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease, Am. J. Physiol. Liver Physiol., 318, G211 Chen, 2021, Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer, Cell. Mol. Immunol., 18, 57, 10.1038/s41423-020-00561-z Shen, 2020, Unveiling the heterogeneity of NKT cells in the liver through single cell RNA sequencing, Sci. Rep., 10, 19453, 10.1038/s41598-020-76659-1 Crosby, 2018, Tissue-specific functions of invariant natural killer T cells, Nat. Rev. Immunol., 18, 559, 10.1038/s41577-018-0034-2 Geissmann, 2005, Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids, PLoS Biol., 3, 0650, 10.1371/journal.pbio.0030113 Tang, 2013, Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease, J. Immunol., 190, 1788, 10.4049/jimmunol.1202814 Kremer, 2010, Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis, Hepatology, 51, 130, 10.1002/hep.23292 Wehr, 2013, Chemokine receptor CXCR6-dependent hepatic NK T cell accumulation promotes inflammation and liver fibrosis, J. Immunol., 190, 5226, 10.4049/jimmunol.1202909 Locatelli, 2013, NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses, Clin. Sci., 124, 279, 10.1042/CS20120289 Syn, 2010, Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease, Hepatology, 51, 1998, 10.1002/hep.23599 Maricic, 2018, Differential activation of hepatic invariant NKT cell subsets plays a key role in progression of nonalcoholic steatohepatitis, J. Immunol., 201, 3017, 10.4049/jimmunol.1800614 Treiner, 2003, Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1, Nature, 422, 164, 10.1038/nature01433 Legoux, 2017, Unconventional or preset αβ T cells: evolutionarily conserved tissue-resident T cells recognizing nonpeptidic ligands, Annu. Rev. Cell Dev. Biol., 33, 511, 10.1146/annurev-cellbio-100616-060725 Hegde, 2018, Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver, Nat. Commun., 9, 2146, 10.1038/s41467-018-04450-y Li, 2018, Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization, Front. Immunol., 9, 1994, 10.3389/fimmu.2018.01994 Chien, 2014, γδ T cells: first line of defense and beyond, Annu. Rev. Immunol., 32, 121, 10.1146/annurev-immunol-032713-120216 Hu, 2021, Single-cell analysis reveals the origins and intrahepatic development of liver-resident IFN-γ-producing γδ T cells, Cell. Mol. Immunol., 18, 954, 10.1038/s41423-021-00656-1 Nakagaki, 2018, Immune and metabolic shifts during neonatal development reprogram liver identity and function, J. Hepatol., 69, 1294, 10.1016/j.jhep.2018.08.018 Jeffery, 2016, Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1, J. Hepatol., 64, 1118, 10.1016/j.jhep.2015.12.017 Salerno-Goncalves, 2014, B cells modulate mucosal associated invariant T cell immune responses, Front. Immunol., 4, 511, 10.3389/fimmu.2013.00511 Aizarani, 2019, A human liver cell atlas reveals heterogeneity and epithelial progenitors, Nature, 572, 199, 10.1038/s41586-019-1373-2 MacParland, 2018, Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations, Nat. Commun., 9, 4383, 10.1038/s41467-018-06318-7 Bruzzì, 2018, B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD), Free Radic. Biol. Med., 124, 249, 10.1016/j.freeradbiomed.2018.06.015 McPherson, 2014, Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease, J. Hepatol., 60, 1055, 10.1016/j.jhep.2014.01.010 Miyake, 2013, B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease, Hepatol. Int., 7, 539, 10.1007/s12072-012-9345-8 Zhang, 2016, Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells, J. Dig. Dis., 17, 464, 10.1111/1751-2980.12362 Barrow, 2021, Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling, Hepatology, 74, 704, 10.1002/hep.31755 Thapa, 2015, Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity, Hepatology, 61, 2067, 10.1002/hep.27761 Shalapour, 2017, Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity, Nature, 551, 340, 10.1038/nature24302 Karl, 2022, Dual roles of B lymphocytes in mouse models of diet-induced nonalcoholic fatty liver disease, Hepatology, 00, 1 El-Agroudy, 2019, Are lifestyle therapies effective for NAFLD treatment? Trends Endocrinol, Metab., 30, 701 Fujiwara, 2022, Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease, Sci. Transl. Med., 14, eabo4474, 10.1126/scitranslmed.abo4474 Warren, 2006, T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells, Hepatology, 44, 1182, 10.1002/hep.21378 Guidotti, 2015, Immunosurveillance of the liver by intravascular effector CD8+ T cells, Cell, 161, 486, 10.1016/j.cell.2015.03.005 Dolina, 2017, Cross-presentation of soluble and cell-associated antigen by murine hepatocytes is enhanced by collectrin expression, J. Immunol., 198, 2341, 10.4049/jimmunol.1502234 Holz, 2008, Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to bim-dependent death, Gastroenterology, 135, 989, 10.1053/j.gastro.2008.05.078 Crispe, 2011, Liver antigen-presenting cells, J. Hepatol., 54, 357, 10.1016/j.jhep.2010.10.005 Poisson, 2017, Liver sinusoidal endothelial cells: physiology and role in liver diseases, J. Hepatol., 66, 212, 10.1016/j.jhep.2016.07.009 Ganesan, 2011, Rapid and efficient clearance of blood-borne virus by liver sinusoidal endothelium, PLoS Pathog., 7, 10.1371/journal.ppat.1002281 Øie, 2020, Liver sinusoidal endothelial cells contribute to the uptake and degradation of entero bacterial viruses, Sci. Rep., 10, 1, 10.1038/s41598-020-57652-0 Øie, 2011, Rat liver sinusoidal endothelial cells (LSECs) express functional low density lipoprotein receptor-related protein-1 (LRP-1), J. Hepatol., 55, 1346, 10.1016/j.jhep.2011.03.013 Thomson, 2010, Antigen-presenting cell function in the tolerogenic liver environment, Nat. Rev. Immunol., 10, 753, 10.1038/nri2858 Carambia, 2014, TGF-β-dependent induction of CD4+CD25+Foxp3 + Tregs by liver sinusoidal endothelial cells, J. Hepatol., 61, 594, 10.1016/j.jhep.2014.04.027 Schurich, 2010, Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells, J. Immunol., 184, 4107, 10.4049/jimmunol.0902580 Schurich, 2009, Distinct kinetics and dynamics of cross-presentation in liver sinusoidal endothelial cells compared to dendritic cells, Hepatology, 50, 909, 10.1002/hep.23075 Schildberg, 2011, Prominent regulatory but weak antigen-presenting cell function of hepatic stellate cells, Hepatology, 54, 1108, 10.1002/hep.24565 Winau, 2007, Ito cells are liver-resident antigen-presenting cells for activating T cell responses, Immunity, 26, 117, 10.1016/j.immuni.2006.11.011 Bomble, 2010, Analysis of antigen-presenting functionality of cultured rat hepatic stellate cells and transdifferentiated myofibroblasts, Biochem. Biophys. Res. Commun., 396, 342, 10.1016/j.bbrc.2010.04.094 Gupta, 2019, Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity, Cytokine, 124, 10.1016/j.cyto.2018.09.004 Shang, 2018, Human hepatic stellate cell isolation and characterization, J. Gastroenterol., 53, 6, 10.1007/s00535-017-1404-4 Payen, 2021, Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity, JHEP Rep., 3 Charles, 2013, Human hepatic stellate cells inhibit t-cell response through B7-H1 pathway, Transplantation, 96, 17, 10.1097/TP.0b013e318294caae Ichikawa, 2011, Hepatic stellate cells function as regulatory bystanders, J. Immunol., 186, 5549, 10.4049/jimmunol.1003917 Dunham, 2013, Hepatic stellate cells preferentially induce Foxp3 + regulatory T cells by production of retinoic acid, J. Immunol., 190, 2009, 10.4049/jimmunol.1201937 Mucida, 2007, Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid, Science, 317, 256, 10.1126/science.1145697 Broomé, 1993, Induced expression of heat-shock protein on biliary epithelium in patients with primary sclerosing cholangitis and primary biliary cirrhosis, Hepatology, 18, 298 Ayres, 1993, Intercellular adhesion molecule- i and MHC antigens on human intrahepatic bile duct cells: effect of proinflammatory cytokines, Gut, 34, 1245, 10.1136/gut.34.9.1245 Leon, 1996, Immunogenicity of biliary epithelium: Investigation of antigen presentation to CD4+ T cells, Hepatology, 24, 561, 10.1002/hep.510240317 Auth, 1993, Establishment and immunological characterization of cultured human gallbladder epithelial cells, Hepatology, 18, 546, 10.1002/hep.1840180311 Schrumpf, 2015, The biliary epithelium presents antigens to and activates natural killer T cells, Hepatology, 62, 1249, 10.1002/hep.27840 Lee, 2020, Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD, Nat. Commun., 11, 4982, 10.1038/s41467-020-18754-5 Sharpton, 2021, Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease, Cell Metab., 33, 21, 10.1016/j.cmet.2020.11.010 Mouries, 2019, Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development, J. Hepatol., 71, 1216, 10.1016/j.jhep.2019.08.005 Rahman, 2016, Loss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol, Gastroenterology, 151, 733, 10.1053/j.gastro.2016.06.022 Sharpton, 2019, Gut microbial metabolism and nonalcoholic fatty liver disease, Hepatol. Commun., 3, 29, 10.1002/hep4.1284 Huh, 2011, Digoxin and its derivatives suppress T H17 cell differentiation by antagonizing RORγ3t activity, Nature, 472, 486, 10.1038/nature09978 Paik, 2022, Human gut bacteria produce ΤΗ17-modulating bile acid metabolites, Nature, 603, 907, 10.1038/s41586-022-04480-z Puchalska, 2018, Isotope tracing untargeted metabolomics reveals macrophage polarization-state-specific metabolic coordination across intracellular compartments, iScience, 9, 298, 10.1016/j.isci.2018.10.029 Glass, 2018, Serum interleukin-8, osteopontin, and monocyte chemoattractant protein 1 are associated with hepatic fibrosis in patients with nonalcoholic fatty liver disease, Hepatol. Commun., 2, 1344, 10.1002/hep4.1237 Honda, 2020, Neutralizing antibody against osteopontin attenuates non-alcoholic steatohepatitis in mice, J. Cell Commun. Signal., 14, 223, 10.1007/s12079-020-00554-7 McFarland, 2021, Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation, Immunity, 54, 1320, 10.1016/j.immuni.2021.03.024 Mikulak, 2019, Hepatic natural killer cells: organ-specific sentinels of liver immune homeostasis and physiopathology, Front. Immunol., 10, 946, 10.3389/fimmu.2019.00946 Vivier, 2011, Innate or adaptive immunity? The example of natural killer cells, Science, 331, 44, 10.1126/science.1198687 Bai, 2021, Liver type 1 innate lymphoid cells develop locally via an interferon-γ–dependent loop, Science (80-. ), 371, eaba4177, 10.1126/science.aba4177 Di Censo, 2021, Granzyme A and CD160 expression delineates ILC1 with graded functions in the mouse liver, Eur. J. Immunol., 51, 2568, 10.1002/eji.202149209 Tang, 2016, Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s, J. Autoimmun., 67, 29, 10.1016/j.jaut.2015.09.004 Zhou, 2019, Liver-resident NK cells control antiviral activity of hepatic T cells via the PD-1-PD-L1 axis, Immunity, 50, 403, 10.1016/j.immuni.2018.12.024 Martínez-Chantar, 2021, Revisiting the role of natural killer cells in non-alcoholic fatty liver disease, Front. Immunol., 12, 10.3389/fimmu.2021.640869 Diedrich, 2020, Characterization of the immune cell landscape of patients with NAFLD, PLoS ONE, 15, 10.1371/journal.pone.0230307 Stiglund, 2019, Retained NK cell phenotype and functionality in non-alcoholic fatty liver disease, Front. Immunol., 10, 1255, 10.3389/fimmu.2019.01255 Fan, 2020, Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment, Liver Int., 40, 598, 10.1111/liv.14307 Cuff, 2019, The obese liver environment mediates conversion of NK cells to a less cytotoxic ILC1-like phenotype, Front. Immunol., 10, 2180, 10.3389/fimmu.2019.02180 Tosello-Trampont, 2016, NKp46+ natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice, Hepatology, 63, 799, 10.1002/hep.28389 Luci, 2019, Natural killer cells and type 1 innate lymphoid cells are new actors in non-alcoholic fatty liver disease, Front. Immunol., 10, 1192, 10.3389/fimmu.2019.01192 Gomez-Santos, 2012, Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase, Hepatology, 56, 747, 10.1002/hep.25694 Gur, 2012, NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis, Gut, 61, 885, 10.1136/gutjnl-2011-301400